Related Experiment Video
Updated: May 20, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis
Xiaoxue Qiu1, Guijie Guo, Ke Chen
1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Abstract:
Suppressors of cytokine signaling 1 and 3 (SOCS-1 and SOCS-3) are inhibitors of the Janus tyrosine kinase (JAK)/signal transducers and activators of transcription (STAT) pathway and function in a negative feedback loop during cytokine signaling. Abl transformation is associated with constitutive activation of JAK/STAT-dependent signaling. However, the mechanism by which Abl oncoproteins bypass SOCS inhibitory regulation remains poorly defined. Here, we demonstrate that coexpression of Bcr-Abl with SOCS-1 or SOCS-3 results in tyrosine phosphorylation of these SOCS proteins. Interestingly, SOCS-1 is highly tyrosine phosphorylated in one of five primary chronic myelogenous leukemia samples. Bcr-Abl-dependent tyrosine phosphorylation of SOCS-1 and SOCS-3 occurs mainly on Tyr 155 and Tyr 204 residues of SOCS-1 and on Tyr 221 residue of SOCS-3. We observed that phosphorylation of these SOCS proteins was associated with their binding to Bcr-Abl. Bcr-Abl-dependent phosphorylation of SOCS-1 and SOCS-3 diminished their inhibitory effects on the activation of JAK and STAT5 and thereby enhanced JAK/STAT5 signaling. Strikingly, disrupting the tyrosine phosphorylation of SOCS-1 or SOCS-3 impaired the expression of Bcl-X(L) protein and sensitized K562 leukemic cells to undergo apoptosis. Moreover, selective mutation of tyrosine phosphorylation sites of SOCS-1 or SOCS-3 significantly blocked Bcr-Abl-mediated tumorigenesis in nude mice and inhibited Bcr-Abl-mediated murine bone marrow transformation. Together, these results reveal a mechanism of how Bcr-Abl may overcome SOCS-1 and SOCS-3 inhibition to constitutively activate the JAK/STAT-dependent signaling, and suggest that Bcr-Abl may critically requires tyrosine phosphorylation of SOCS-1 and SOCS-3 to mediate tumorigenesis when these SOCS proteins are present in cells.
Insights
Bcr-Abl oncoproteins overcome Suppressors of Cytokine Signaling (SOCS-1/3) inhibition through tyrosine phosphorylation, enhancing JAK/STAT signaling. This phosphorylation is crucial for Bcr-Abl-mediated tumorigenesis and leukemic cell survival.
Area of Science:
- Molecular Biology
- Oncology
- Signal Transduction
Background:
- Suppressors of cytokine signaling (SOCS-1 and SOCS-3) are key negative regulators of the Janus tyrosine kinase (JAK)/signal transducers and activators of transcription (STAT) pathway.
- Constitutive activation of JAK/STAT signaling is a hallmark of Abl-driven leukemias, but the mechanisms by which Abl oncoproteins evade SOCS-mediated inhibition are not fully understood.
Purpose of the Study:
- To elucidate the mechanism by which Bcr-Abl oncoproteins overcome SOCS-1 and SOCS-3 inhibitory regulation.
- To investigate the role of Bcr-Abl-induced tyrosine phosphorylation of SOCS proteins in regulating JAK/STAT signaling and mediating tumorigenesis.
Main Methods:
- Coexpression of Bcr-Abl with SOCS-1 or SOCS-3 in cellular systems.
- Analysis of tyrosine phosphorylation sites on SOCS proteins using mass spectrometry.
- Assessment of JAK/STAT pathway activation and downstream target gene expression (e.g., Bcl-X(L)).
- In vivo studies using nude mice and murine bone marrow transformation assays to evaluate tumorigenesis.
Main Results:
- Bcr-Abl induces tyrosine phosphorylation of SOCS-1 and SOCS-3, primarily at specific tyrosine residues (Tyr155/204 for SOCS-1, Tyr221 for SOCS-3).
- This phosphorylation facilitates SOCS binding to Bcr-Abl, diminishes their inhibitory capacity on JAK/STAT5 signaling, and enhances pathway activation.
- Disruption of SOCS tyrosine phosphorylation impairs Bcl-X(L) expression, sensitizes cells to apoptosis, and significantly blocks Bcr-Abl-mediated tumorigenesis in vivo.
Conclusions:
- Bcr-Abl overcomes SOCS-1 and SOCS-3 inhibition via tyrosine phosphorylation, leading to constitutive JAK/STAT activation.
- Tyrosine phosphorylation of SOCS proteins is a critical mechanism for Bcr-Abl-mediated oncogenesis, impacting cell survival and tumor development.
- Targeting SOCS tyrosine phosphorylation represents a potential therapeutic strategy for Bcr-Abl-associated malignancies.
Related Concept Videos
Abnormal Proliferation
Anaphase Promoting Complex
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Inhibition of Cdk Activity
The Ras Gene
Ras is a superfamily...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

